Abiopharma

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Financial Statements and Related Announcement: Full Yearly Results

Grey symbol attribute type Security_Name was changed. Previous value: CHEELCARE INC. New value: PHARMCHEM INC.

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Financial Statements and Related Announcement: Second Quarter and/ or Half Yearly Results

Mandatory Cash Dividend/ Distribution:

General Announcement: MONTHLY UPDTAE ON BANKRUPTCY LIQUIDATION OF A SUBSIDIARY OF THE COMPANY

FDA approve BUROSUMAB-TWZA

FDA approve PARICALCITOL

FDA approve LIRAGLUTIDE

FDA approve LIDOCAINE HYDROCHLORIDE

Becoming a substantial holder

Smith+Nephew PLC Notification

NEOG Investors Have Opportunity to Lead Neogen Corporation Securities Fraud Lawsuit

Q & M Dental Group (Singapore) Limited - Announcement